These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 672414)

  • 1. Psychotomimetic phenalkylamines as serotonin agonists: an SAR analysis.
    Kier LB; Glennon RA
    Life Sci; 1978 May; 22(18):1589-93. PubMed ID: 672414
    [No Abstract]   [Full Text] [Related]  

  • 2. Directional lipophilic character in a series of psychotomimetic phenethylamine derivatives.
    Nichols DE; Shulgin AT; Dyer DC
    Life Sci; 1977 Aug; 21(4):569-75. PubMed ID: 904435
    [No Abstract]   [Full Text] [Related]  

  • 3. Congeners of DOM: effect of distribution of the evaluation of pharmacologic data.
    Barfknecht CF; Caputo JF; Tobin MB; Dyer DC; Standirdge RT; Howell HG; Goodwin WR; Partyka RA; Gylys JA; Cavanagh RL
    NIDA Res Monogr; 1978; (22):16-26. PubMed ID: 101880
    [No Abstract]   [Full Text] [Related]  

  • 4. Conformational studies on phenethylamine hallucinogens: the role of alpha alkyl substitution.
    Makriyannis A; Knittel J
    NIDA Res Monogr; 1978; (22):464-78. PubMed ID: 101888
    [No Abstract]   [Full Text] [Related]  

  • 5. Indolealkylamine and phenalkylamine hallucinogens: a brief overview.
    Glennon RA; Rosecrans JA
    Neurosci Biobehav Rev; 1982; 6(4):489-97. PubMed ID: 6757811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress with several models for the study of the SAR of hallucinogenic agents.
    Kier LB; Glennon RA
    NIDA Res Monogr; 1978; (22):159-85. PubMed ID: 101879
    [No Abstract]   [Full Text] [Related]  

  • 7. Potent agonist activity of DOB at 5-HT2 receptors in guinea pig trachea.
    Heller WA; Baraban JM
    Eur J Pharmacol; 1987 Jun; 138(1):115-7. PubMed ID: 3622603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity studies on hallucinogenic amphetamines using molecular connectivity.
    Kier LB; Hall LH
    J Med Chem; 1977 Dec; 20(12):1631-6. PubMed ID: 592329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of chirality on serotonin receptor affinity.
    Glennon RA
    Life Sci; 1979 Apr; 24(16):1487-92. PubMed ID: 470548
    [No Abstract]   [Full Text] [Related]  

  • 10. Psychotomimetic phenylisopropylamines. 5. 4-Alkyl-2,5-dimethoxyphenylisopropylamines.
    Shulgin AT; Dyer DC
    J Med Chem; 1975 Dec; 18(12):1201-4. PubMed ID: 1195275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of psychotomimetic activity of phenethylamines and amphetamines with 1-octanol-water partition coefficients.
    Barfknecht CF; Nichols DE
    J Med Chem; 1975 Feb; 18(2):208-10. PubMed ID: 1120990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of [3H]5-HT binding to rat brain membranes by psychotomimetic amphetamines.
    De Jong AP; Huggins F; Fournier D; Makriyannis A
    Eur J Pharmacol; 1982 Sep; 83(3-4):305-8. PubMed ID: 7173311
    [No Abstract]   [Full Text] [Related]  

  • 13. Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors.
    Moya PR; Berg KA; Gutiérrez-Hernandez MA; Sáez-Briones P; Reyes-Parada M; Cassels BK; Clarke WP
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1054-61. PubMed ID: 17337633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unreliability of the rat stomach fundus as a predictor of hallucinogenic activity in substituted phenethylamines.
    Nichols DE; Schooler D; Yeung MC; Oberlender RA; Zabik JE
    Life Sci; 1984 Sep; 35(13):1343-8. PubMed ID: 6482656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychotomimetic drugs: biochemistry and pharmacology.
    Brimblecombe RW
    Adv Drug Res; 1973; 7():165-206. PubMed ID: 4613150
    [No Abstract]   [Full Text] [Related]  

  • 16. QSAR studies on psychotomimetic phenylalkylamines.
    Gupta SP; Handa A; Bindal MC; Singh P
    Arzneimittelforschung; 1983; 33(8):1089-90. PubMed ID: 6685483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A common mechanism for lysergic acid, indolealkylamine and phenethylamine hallucinogens: serotonergic medication of behavioral effects in rats.
    Sloviter RS; Drust EG; Damiano BP; Connor JD
    J Pharmacol Exp Ther; 1980 Aug; 214(2):231-8. PubMed ID: 6104720
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation between activity and electronic state of hallucinogenic amphetamines.
    Kang S; Green JP
    Nature; 1970 May; 226(5246):645. PubMed ID: 5444928
    [No Abstract]   [Full Text] [Related]  

  • 19. Indoleamine and the phenethylamine hallucinogens: mechanisms of psychotomimetic action.
    Marek GJ; Aghajanian GK
    Drug Alcohol Depend; 1998; 51(1-2):189-98. PubMed ID: 9716940
    [No Abstract]   [Full Text] [Related]  

  • 20. Structure-activity correlations for psychotomimetics. 1. Phenylalkylamines: electronic, volume, and hydrophobicity parameters.
    Clare BW
    J Med Chem; 1990 Feb; 33(2):687-702. PubMed ID: 2299636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.